Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04249219 · ClinicalTrials.gov registry record · Early Phase 1
Responses to E-Cigarette Advertising
A Early Phase 1 study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 62
- Enrollment target
NCT04249219 is a Early Phase 1 study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 62 participants.
The verdict
NCT04249219, a Early Phase 1 study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 62 participants
- Enrollment target
Study Summary
While conventional cigarette use continues to decline among youth and young adults, e-cigarette (EC) use is on the rise. The use of ECs during young adulthood, particularly 18 years of age, is especially alarming because it is not only a critical period in development but also a time when tobacco use is established. Additionally, the tobacco industry targets individuals of this age with the hope that they will one day progress to using combustible cigarettes. Advertising may be one of the reasons leading young people to use ECs, and the Food and Drug Administration (FDA) now has the authority to regulate EC advertisement features. The goal of the study is to determine which EC ad features most strongly influence young adults' attitudes, susceptibility, and intentions to use ECs. Fifteen ads from the most popular EC brands that employ a brand, product descriptions, and modeling features were selected. Young adults who are susceptible to EC use will come into the lab and view these ads. During exposure, they will be assessed for real-time visual attention using eye-tracking, orienting responses using heart rate, and arousal using skin conductance as well as pre- and post-ad self-report measures of attitudes, susceptibility, and behavioral intentions. These factors will help determine the most high impact features, which will be associated with the greatest visual attention, orienting responses, and arousal levels and changes in attitudes. Findings from this study will provide public health officials important and urgently needed information as to what advertising features are contributing to the sharp rise in the use of ECs among young adults.
Interventions
- OTHER Viewing e-cigarette ads
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2021-08-04 |
| Est. Completion | 2022-08-15 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04249219
The ClinicalTrials.gov registry entry for NCT04249219 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Viewing e-cigarette ads is the first listed.
NCT04249219 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04249219 about?
NCT04249219 is a clinical study titled "Responses to E-Cigarette Advertising". While conventional cigarette use continues to decline among youth and young adults, e-cigarette (EC) use is on the rise. The use of ECs during young adulthood, particularly 18 years of age, is especially alarming because it is not only a critical period in development but also a time when tobacco us...
What is the current status of trial NCT04249219?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 62 participants. The study started on 2021-08-04. Estimated completion is 2022-08-15.
What interventions are being tested in trial NCT04249219?
The interventions under investigation include: Viewing e-cigarette ads (OTHER).
Who is sponsoring clinical trial NCT04249219?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.